CellFiber's Partner Locus Cell Establishes Large-Scale Manufacturing Process for Human Umbilical Cord-Derived Mesenchymal Stem Cells Using CellFiber® Technology

CellFiber Inc. (Headquarters: Koto-ku, Tokyo; CEO: Kazuya Furuishi), a company aiming to contribute to cell therapy through its cell culture technology, announces that its Asian market collaboration partner, Locus Cell Co., Ltd. (Headquarters: Taiwan), has established a commercial-scale mass manufacturing process for human umbilical cord-derived mesenchymal stem cells (UC-MSCs) using CellFiber® technology. The CellFiber® technology is CellFiber's proprietary next-generation platform that enables the efficient manufacturing of high-quality cells. It is an encapsulation technology that forms a tube-like structure with alginate gel to protect cells inside the tube. Cells cultured with this technology are expected to have improved function, long-term viability, and quality uniformity compared to conventional methods. Locus Cell has introduced the CellFiber® technology to establish a GMP-compliant large-scale manufacturing process for human umbilical cord-derived mesenchymal stem cells. This manufacturing process has now been fully automated with the official launch of Locus Cell's Zhubei automated smart factory and has been validated as a large-scale cell manufacturing process for cell-based medicinal products. Under its mission to deliver Japan-originated innovative cell culture technology to the world and contribute to the popularization of cell therapy, CellFiber will continue to promote the business development of CellFiber® technology in the Asian market through its collaboration with Locus Cell, contributing to the spread of regenerative and cell medicine. About Locus Cell Co., Ltd. Locus Cell Co., Ltd. is a biotechnology company based in Hsinchu, Taiwan. As a CDMO (Contract Development and Manufacturing Organization) specializing in GMP-compliant cell manufacturing, it promotes large-scale commercial manufacturing in the regenerative and cell medicine fields. It boasts one of Asia's largest automated smart factories in Zhubei and actively pursues strategic partnerships with biopharmaceutical companies in Japan, Europe, and the United States. About CellFiber Inc. CellFiber is a biotechnology company established in 2015 based on its 'CellFiber® technology,' an encapsulation technology that forms a tube-like structure with alginate gel to protect cells inside. With the purpose of “Cell Culture Reimagined for Life,” the company is developing mass cell culture technologies to contribute to the efficient development and manufacturing of cell and gene therapy products and improve patients' quality of life. Company Name: CellFiber Inc. Headquarters: MSC Fukagawa Bldg. 2, #105, 2-9-8 Saga, Koto-ku, Tokyo 135-0031, Japan Representative: Kazuya Furuishi, President & CEO Established: April 1, 2015 Business: Research, development, production, and sales of biological materials including cells and soft materials. Official Website: https://cellfiber.jp/